跳至主要内容
临床试验/NCT06069102
NCT06069102
已完成
4 期

OPT-BP: Optimal Blood Pressure Treatment Thresholds Following a Hypertensive Disorder of Pregnancy: A Pilot Trial

Alisse Hauspurg1 个研究点 分布在 1 个国家目标入组 61 人2023年11月15日

概览

阶段
4 期
干预措施
Usual care
疾病 / 适应症
Hypertensive Disorder of Pregnancy
发起方
Alisse Hauspurg
入组人数
61
试验地点
1
主要终点
Percent of participants eligible, enrolled and retained (feasibility)
状态
已完成
最后更新
3个月前

概览

简要总结

The objective of this research project is to conduct a single-site pilot trial within our institution's clinical remote blood pressures (BP) management program to assess the feasibility and effect of tight blood pressure control versus usual care in the immediate postpartum period after a hypertensive disorder of pregnancy (HDP).

The investigators' central hypothesis is that tight blood pressure control will be feasible and acceptable to postpartum individuals and will result in lower BP at six months postpartum and a reduction in postpartum hospital readmissions. Subjects will undergo 3 study visits (1 in-person and 2 remote) involving BP measurements, blood draws, and/or questionnaires. Up to 60 adult subjects will be enrolled at Magee-Women's Hospital.

详细描述

The investigators will determine the feasibility of conducting a randomized controlled trial of tight blood pressure control (\<135/85 mmHg on home BP monitoring) vs. standard of care (\<150/100 mmHg on home BP monitoring) in postpartum individuals following a HDP with assessment of individuals who are eligible, enrolled, and remain in the study until six weeks postpartum. Individuals who are retained in the study for 6 months postpartum. Lastly, investigators will analyze effect outcomes to inform the sample size for a subsequent large-scale randomized trial. This will be done through analysis of mean arterial pressure (MAP), systolic blood pressure, and diastolic blood pressure of participants at 6 weeks and at 6 months postpartum. The study will be conducted on the postpartum unit of Magee-Womens Hospital. Participants will be enrolled at the time of postpartum hospitalization with study visit #1 occurring in the hospital. At this study visit, participants will be administered questionnaires, will provide a blood sample, and BP will be measured. Study visit #2 will be a remote study visit conducted via telemedicine or a telephone call at 6 weeks postpartum. At this visit, participants will provide questionnaires and blood pressure data. Study visit #3 will be a remote study visit conducted via telemedicine or a telephone call at 6 months postpartum. At this visit, participants will again provide questionnaires and blood pressure data.

注册库
clinicaltrials.gov
开始日期
2023年11月15日
结束日期
2025年12月1日
最后更新
3个月前
研究类型
Interventional
研究设计
Parallel
性别
Female

研究者

发起方
Alisse Hauspurg
责任方
Sponsor Investigator
主要研究者

Alisse Hauspurg

Assistant Professor

University of Pittsburgh

入排标准

入选标准

  • Postpartum individuals ≥18 years old
  • Preeclampsia or gestational hypertension diagnosis (complying ACOG criteria)
  • Enrolled in remote BP management program.

排除标准

  • Pre-pregnancy hypertension
  • Pre-pregnancy diabetes
  • Maternal cardiac disease
  • Chronic kidney disease

研究组 & 干预措施

Usual Care Group

Standard of care BP medication will usually be started if a subject's BP consistently exceeds 150/100 mmHg at any point.

干预措施: Usual care

Intervention (Tight Blood Pressure Control) Group

BP medication will be started if a subject's hospital BP consistently exceeds 140/90 mmHg or her home BP consistently exceeds 135/85 mmHg.

干预措施: Tight blood pressure control

结局指标

主要结局

Percent of participants eligible, enrolled and retained (feasibility)

时间窗: Baseline to approximately 6 months postpartum

To determine if a randomized controlled trial of tight blood pressure control (\<135/85 mmHg on home blood pressure monitoring) vs. standard of care (\<150/100 mmHg on home blood pressure monitoring) in postpartum individuals following a hypertensive disorder of pregnancy (HDP) is feasible.

次要结局

  • Anti-hypertensive medication use(6 weeks postpartum)
  • Change in diastolic BP(Enrollment to 6 weeks postpartum)
  • Change in MAP(Enrollment to 6 weeks postpartum)
  • Change in systolic BP(Enrollment to 6 weeks postpartum)
  • Mean arterial pressure (efficacy)(6 months postpartum)
  • Anti-hypertensive medication use (efficacy)(6 months postpartum)
  • Diastolic blood pressure(6 weeks postpartum)
  • Mean arterial pressure(6 weeks postpartum)
  • Systolic blood pressure(6 months postpartum)
  • Proportion of participants with readmissions(Enrollment through six months postpartum)
  • Proportion of participants with ER visits(Enrollment through six months postpartum)
  • Diastolic blood pressure(6 months postpartum)

研究点 (1)

Loading locations...

相似试验